Real Time Release Testing and Parametric Release
Annex 17 of the EU GMP Guide describes the requirements for Real Time Release Testing (RTRT) and the specific case of parametric release. RTRT allows a manufacturer to assess and assure the quality of in-process or finished product based on process data (including validated PAT and in-process controls) instead of end-product testing. Parametric release is the RTRT sub-case where sterility assurance of terminally sterilised products is based on validated process parameters rather than a sterility test.
What this does not cover
stated in the document's own scope- Parametric release applies to terminal sterilisation only, not to aseptic processing
- Does not authorise RTRT unless the approach is in the approved marketing authorisation
- Does not set analytical method validation requirements — see ICH Q2(R2)
- Does not cover general batch release/QP duties in full — see Annex 16
Always verify against the current published text before relying on it for a submission or inspection.
Overview
Annex 17 of the EU GMP Guide (EudraLex Volume 4) sets out requirements for Real Time Release Testing (RTRT) and parametric release. RTRT is the ability to evaluate and assure the quality of in-process or finished product based on process data — such as validated in-process controls and Process Analytical Technology (PAT) — rather than on end-product testing. Parametric release is the specific application of RTRT to the sterility assurance of terminally sterilised products, based on validated sterilisation process parameters instead of a finished-product sterility test. The annex describes prerequisites, the control strategy, handling of situations where real time data are unavailable, and batch certification implications.
Legal basis & how it acquires force
Annex 17 is part of the EU GMP Guide, which gives effect to the GMP obligations in Directive 2003/94/EC (and Regulation (EU) 2017/1569 for investigational products). It is legally binding on EU/EEA manufacturers through their manufacturing authorisation, and the approved RTRT/parametric release approach must be reflected in the product marketing authorisation.
Document structure
| Part | Covers |
|---|---|
| Scope and principle | Definition of RTRT and parametric release; general principles |
| Real time release testing | Control strategy, validated methods/PAT, fallback when data are unavailable |
| Parametric release | Sterility assurance of terminally sterilised product via validated parameters |
| Batch certification | QP certification based on the real time data and marketing-authorisation alignment |
| Glossary | Defined terms used in the annex |
Key requirements
- Base release on a control strategy that assures product meets its specification in real time
- Validate the RTRT method and any PAT models, including maintenance and revalidation triggers
- Define a fallback strategy for when RTRT data are unavailable or out of specification
- For parametric release, base sterility assurance on validated terminal sterilisation parameters
- Ensure the marketing authorisation reflects the approved RTRT/parametric release approach
- Maintain the qualified person (QP) certification decision on the real time data set
- Establish that combined in-process results give assurance equivalent to or greater than end testing
Implementation tips
- Design and register the fallback (end-product test) path — regulators expect a defined contingency
- Keep PAT model lifecycle governance explicit; drift management is part of the control strategy
- Parametric release applies to terminal sterilisation only — do not extend it to aseptic processing
- Confirm the RTRT approach is in the authorised dossier before relying on it for QP certification
International alignment
Annex 17 is an EU GMP standard; PIC/S maintains a corresponding GMP guide annex, giving broadly equivalent expectations across PIC/S participating authorities. It is consistent with ICH Q8-Q12 concepts (control strategy, PAT, lifecycle) that underpin real time release approaches.
EU GMP Annex 17: frequently asked questions
Quick answers to common questions about EU GMP Annex 17.
Can parametric release be used for aseptically filled products?
No. Parametric release under Annex 17 applies to terminally sterilised products based on validated sterilisation parameters.
Does RTRT remove the need for a registered method?
No. The RTRT approach and its control strategy must be described in the approved marketing authorisation.
What happens if real time data are unavailable for a batch?
A defined fallback strategy (e.g. end-product testing) must be in place, as described in the annex.